Higher Serum sTNFR1 Level Predicts Conversion from Mild Cognitive Impairment to Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2011-01-07

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.3233/JAD-2010-100921PMID 20930310
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression.

  2010cited by this paper
• Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment.

  2010cited by this paper
• Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients.

  2010cited by this paper
• Neuropathology and the Neuroinflammation Idea

  2009cited by this paper
• Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease

  2009cited by this paper
• Increased soluble tumor necrosis factor‐α receptors in patients with major depressive disorder

  2009cited by this paper
• Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway.

  2009cited by this paper
• TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

  2008cited by this paper
• Neuropsychological profile of Brazilian older adults with heterogeneous educational backgrounds.

  2008cited by this paper
• All-or-nothing type biphasic cytokine production of human lymphocytes after exposure to Alzheimer's beta-amyloid peptide.

  2008cited by this paper
• Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic

  2008cited by this paper
• Increased Serum Levels of Inflammatory Markers in Chronic Institutionalized Patients with Schizophrenia

  2008cited by this paper
• Mild cognitive impairment: cognitive screening or neuropsychological assessment?

  2008cited by this paper
• CAMcog as a screening tool for diagnosis of mild cognitive impairment and dementia in a Brazilian clinical sample of moderate to high education

  2008cited by this paper
• INFLAMMATORY MARKERS AND THE RISK OF ALZHEIMER DISEASE: THE FRAMINGHAM STUDY

  2008cited by this paper
• Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine.

  2008cited by this paper
• Targeting TNF-alpha receptors for neurotherapeutics.

  2008cited by this paper
• Connecting TNF-α Signaling Pathways to iNOS Expression in a Mouse Model of Alzheimer's Disease: Relevance for the Behavioral and Synaptic Deficits Induced by Amyloid β Protein

  2007cited by this paper
• Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.

  2007cited by this paper
• Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein.

  2007cited by this paper
• Inflammatory markers and the risk of Alzheimer disease

  2007cited by this paper
• Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

  2006cited by this paper
• Tumor necrosis factor signaling

  2003cited by this paper
• Intrathecal inflammation precedes development of Alzheimer’s disease

  2003cited by this paper
• Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

  2003cited by this paper
• Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease.

  2002cited by this paper
• Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8.

  2002cited by this paper
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• Inflamm‐aging: An Evolutionary Perspective on Immunosenescence

  2000cited by this paper
• Allelic discrimination using fluorogenic probes and the 5' nuclease assay.

  1999cited by this paper
• Clinical diagnosis of Alzheimer's disease

  1984cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper

• Premature aging in serious mental illness.

  2026cites this paper
• Association of soluble tumor necrosis factor receptor 1 with tau pathology, brain atrophy, and cognitive decline: a longitudinal study.

  2026cites this paper
• Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy

  2025cites this paper
• Beyond plaques and tangles: the role of Immune Cell Dysfunction in Alzheimer's disease.

  2025cites this paper
• Multiplexing Proteomic and Ingenuity Pathway Analysis of Attention/Working Memory in Virally Suppressed Women with HIV: A Feasibility Study

  2025cites this paper
• Acute experimental colitis in 5xFAD Alzheimer's disease mice leads to enhanced monocyte infiltration into the brain accompanied by reduced β‐amyloid deposition

  2025cites this paper
• Inflammatory Markers Associated with Physical Frailty and Cognitive Impairment

  2024cites this paper
• Circulating biomarkers of inflammaging and Alzheimer's disease to track age-related trajectories of dementia: can we develop a clinically relevant composite combination?

  2024cites this paper
• The brain pathobiome in Alzheimer's disease

  2024cites this paper
• NF-κB in Alzheimer’s Disease: Friend or Foe? Opposite Functions in Neurons and Glial Cells

  2024cites this paper
• Recent Advances in the Treatment and Management of Alzheimer's Disease: A Precision Medicine Perspective.

  2024cites this paper
• Personality and Cognition: The Mediating Role of Inflammatory Markers.

  2023cites this paper
• A systematic review of exercise modalities that reduce pro-inflammatory cytokines in humans and animals' models with mild cognitive impairment or dementia.

  2023cites this paper
• Determination of soluble tumor necrosis factor receptor II and secretory immunoglobulin A in saliva of patients with dementia

  2023cites this paper
• Mid‐life leukocyte telomere length and dementia risk: An observational and mendelian randomization study of 435,046 UK Biobank participants

  2023cites this paper
• Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease

  2022cites this paper
• CSF TNF α levels were associated with conversion from mild cognitive impairment to dementia

  2022cites this paper
• Mid-life leukocyte telomere length and dementia risk: a prospective cohort study of 435,046 UK Biobank participants

  2022cites this paper
• Age-associated alterations in immune function and inflammation.

  2022cites this paper
• Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults

  2022influential citation
• Factors Associated with Apathy in Alzheimer’s Disease: A Cross-Sectional Analysis of the Texas Alzheimer’s Research and Care Consortium (TARCC) Study

  2022cites this paper
• A High Neutrophil-to-Lymphocyte Ratio Predicts Higher Risk of Poststroke Cognitive Impairment: Development and Validation of a Clinical Prediction Model

  2022cites this paper
• Assessment of serum Levels of Adiponectin and Leptin in a cohort of elderly Egyptian Patients with Dementia

  2021cites this paper
• Peripheral Inflammatory Biomarkers Predict the Deposition and Progression of Amyloid-β in Cognitively Unimpaired Older Adults.

  2021cites this paper
• Tumor necrosis factor superfamily molecules are increased in behavioral variant frontotemporal dementia and correlate with cortical atrophy: An exploratory investigation.

  2021cites this paper
• The clinical correlation of proinflammatory and anti-inflammatory biomarkers with Alzheimer disease: a meta-analysis

  2021cites this paper
• Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?

  2021cites this paper
• Peripheral and central immune system crosstalk in Alzheimer disease — a research prospectus

  2021cites this paper
• Tumor Necrosis Factor Alpha: Role in the Development of Obesity and Diabetes Mellitus

  2020cites this paper
• Patients with obstructive sleep apnea have suppressed levels of soluble cytokine receptors involved in neurodegenerative disease, but normal levels with airways therapy

  2020cites this paper
• TNF receptors are associated with tau pathology and conversion to Alzheimer's dementia in subjects with mild cognitive impairment.

  2020cites this paper
• Coronavirus Disease-2019 Conundrum: RAS Blockade and Geriatric-Associated Neuropsychiatric Disorders

  2020cites this paper
• Sildenafil for the Treatment of Alzheimer’s Disease: A Systematic Review

  2020cites this paper
• Frailty and cognitive decline.

  2020cites this paper
• Influence of plasma cytokine levels on the conversion risk from MCI to dementia in the Alzheimer's disease neuroimaging initiative database.

  2020cites this paper
• Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults.

  2020cites this paper
• The effect of a 6-month ketogenic medium-chain triglyceride supplement on plasma cardiometabolic and inflammatory markers in mild cognitive impairment.

  2020cites this paper
• Early chronic systemic inflammation and associations with cognitive performance after moderate to severe TBI

  2020cites this paper
• A cross-sectional examination of a family history of Alzheimer's disease and ApoE epsilon 4 on physical fitness, molecular biomarkers, and neurocognitive performance.

  2020cites this paper
• Effects of Aerobic and Resistance Exercise Interventions on Cognitive and Physiologic Adaptations for Older Adults with Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Randomized Control Trials

  2020cites this paper
• Inflammation and Preclinical AD: Associations between Peripheral Inflammatory Biomarkers, Cognition, and Amyloid-B deposition in Non-demented Older Adults

  2019influential citation
• Plasma Markers of Inflammation Linked to Clinical Progression and Decline During Preclinical AD

  2019cites this paper
• Peripheral inflammatory biomarkers in Alzheimer's disease and mild cognitive impairment: a systematic review and meta‐analysis

  2019cites this paper
• T and B cell subsets differentially correlate with amyloid deposition and neurocognitive function in patients with amnestic mild cognitive impairment after one year of physical activity.

  2019cites this paper
• Distinctive Effects of Aerobic and Resistance Exercise Modes on Neurocognitive and Biochemical Changes in Individuals with Mild Cognitive Impairment.

  2019cites this paper
• Epidermal growth factor and fibroblast growth factor-2 circulating levels in elderly with major depressive disorder.

  2019cites this paper
• The Role of Physical Fitness in Cognitive-Related Biomarkers in Persons at Genetic Risk of Familial Alzheimer’s Disease

  2019cites this paper
• Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer’s Disease Pathology and Neuronal Damage

  2018cites this paper
• Acute phase response after fatal traumatic brain injury

  2018cites this paper
• Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease

  2018cites this paper
• Association Between Serum Tumor Necrosis Factor Receptor 1 and Trajectories of Functional Status: The Northern Manhattan Study

  2017cites this paper
• Stress and its impact on cognition in mild cognitive impairment

  2017cites this paper
• Cell Death Pathways: a Novel Therapeutic Approach for Neuroscientists

  2017cites this paper
• Aerobic exercise improves quality of life, psychological well-being and systemic inflammation in subjects with Alzheimer's disease.

  2017cites this paper
• Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies

  2017cites this paper
• Serum Levels of high Molecular Weight Adiponectin and Leptin in Elderly Patients with Dementia

  2016cites this paper
• Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease.

  2016cites this paper
• Association of Inflammation and Possible Mild Cognitive Decline Measured by the Stroop Cognitive Function Test

  2016cites this paper
• Brain-derived neurotrophic factor: a mediator of inflammation-associated neurogenesis in Alzheimer’s disease

  2016cites this paper
• Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies

  2016cites this paper
• Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease in focal cerebral ischemic rats.

  2016cites this paper
• Serum Levels of high Molecular Weight Adiponectin and Leptin in Elderly Patients with Dementia

  2016cites this paper
• Elevated platelet microparticles levels are associated with lipidic oxidation and inflammatory profiles in Alzheimer's disease

  2016cites this paper
• Allergy and Alzheimer disease

  2015cites this paper
• Tumor necrosis factor alpha and its receptors in behaviour and neurobiology of adult mice, in the absence of an immune challenge.

  2015cites this paper
• Targeting of Tumor Necrosis Factor Alpha Receptors as a Therapeutic Strategy for Neurodegenerative Disorders

  2015cites this paper
• Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity

  2015cites this paper
• Supporting evidence for using Perispinal Etanercept to inhibit TNFα when treating neuropathologies including dementia, chronic stroke, neuropathic pain or traumatic brain injury: Clinical outcomes and role of TNF in neuropathologies other than Alzheimer’s Dementia (Part III)

  2015cites this paper
• Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals

  2015cites this paper
• Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis

  2015influential citation
• Nutrigenomics, Inflammaging, and Osteoarthritis: A Review

  2015cites this paper
• Age-Related Differences in Biomarkers of Acute Inflammation During Hospitalization for Sepsis

  2014cites this paper
• Personalized Medicine of Alzheimer’s Disease

  2014cites this paper
• Special Issue on Biomarkers , Inflammation , and Frailty Simple Biologically Informed Inflammatory Index of Two Serum Cytokines Predicts 10 Year All-Cause Mortality in Older Adults

  2014cites this paper
• The relationship between exercise and cognition in diabetes mellitus

  2014cites this paper
• Inflamm-aging does not simply reflect increases in pro-inflammatory markers.

  2014cites this paper
• Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study

  2014cites this paper
• Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease.

  2014influential citation
• Physical exercise in MCI elderly promotes reduction of pro-inflammatory cytokines and improvements on cognition and BDNF peripheral levels.

  2014cites this paper
• Simple biologically informed inflammatory index of two serum cytokines predicts 10 year all-cause mortality in older adults.

  2014cites this paper
• Plasma levels of soluble tumor necrosis factor receptors are associated with cognitive performance in Parkinson's disease

  2014cites this paper
• Body Fluid Cytokine Levels in Mild Cognitive Impairment and Alzheimer’s Disease: a Comparative Overview

  2014influential citation
• MiR-206 decreases brain-derived neurotrophic factor levels in a transgenic mouse model of Alzheimer’s disease

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• Adiponectin as a new paradigm for approaching Alzheimer's disease

  2013cites this paper
• Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan Study.

  2013cites this paper
• Immune Profiling in Blood Identifies sTNF-R1 Performing Comparably Well as Biomarker Panels for Classification of Alzheimer's Disease Patients

  2013cites this paper
• sTNFr1 and it's contributory role in the evolution and progression of different psychiatric disorders

  2013cites this paper
• Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship

  2013cites this paper
• Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.

  2013cites this paper
• Is There a Causal Link between Inflammation and Dementia?

  2013cites this paper
• P2–005: Low platelet PLA2 activity predicts conversion from mild cognitive impairment to Alzheimer's disease: A 4‐year follow‐up study

  2013cites this paper
• Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors

  2012cites this paper
• Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease

  2012cites this paper
• Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder.

  2012cites this paper
• Reduced platelet amyloid precursor protein ratio (APP ratio) predicts conversion from mild cognitive impairment to Alzheimer’s disease

  2012cites this paper
• Circulating Glial-derived neurotrophic factor is reduced in late-life depression.

  2012influential citation
• Transcriptional Alterations Related to Neuropathology and Clinical Manifestation of Alzheimer’s Disease

  2012cites this paper
• Beyond amyloid: the future of therapeutics for Alzheimer's disease.

  2012cites this paper